Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Evans, T.R. Jeffry"'
Autor:
Sacco, Joseph J., Jackson, Richard, Corrie, Pippa, Danson, Sarah, Evans, T.R. Jeffry, Ochsenreither, Sebastian, Kumar, Satish, Goodman, Andrew, Larkin, James, Karydis, Ioannis, Steven, Neil, Lorigan, Paul, Plummer, Ruth, Patel, Poulam, Psarelli, Eftychia, Olsson-Brown, Anna, Shaw, Heather, Leyvraz, Serge, Handley, Louise, Rawcliffe, Charlotte, Nathan, Paul
Publikováno v:
In European Journal of Cancer May 2024 202
Autor:
Reig, Maria, Evans, T.R. Jeffry, Chon, Hong Jae, Lim, Ho Yeong, Ryu, Min-Hee, Kim, Do Young, Macarulla, Teresa, Gomez-Martin, Carlos, Moreno, Victor, Haugk, Beate, Ness, Thomas, Baumann, Pia, Bhoi, Sujata, Jensen, Malene, Tunblad, Karin, Wallberg, Hans, Oberg, Fredrik, Heo, Jeong
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p476-476, 151p
Autor:
Sun, Jong-Mu, Chao, Yee, Kim, Sung-Bae, Rha, Sun Young, Evans, T.R. Jeffry, Strickland, Andrew, Wainberg, Zev A., Chau, Ian, Pelles-Avraham, Sharon, Ajani, Jaffer A., Malhotra, Ritu, Liu, Qingyuan, Li, Sijing, Cha, Edward, Rahalkar, Swapna, Allen, Simon, Hsu, Chih-Hung
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p324-324, 185p
Autor:
Cairney, Claire J., Bilsland, Alan E., Evans, T.R. Jeffry, Roffey, Jon, Bennett, Dorothy C., Narita, Masashi, Torrance, Christopher J., Keith, W. Nicol
Publikováno v:
In Drug Discovery Today March 2012 17(5-6):269-276
Autor:
Morton, Jennifer P., Jamieson, Nigel B., Karim, Saadia A., Athineos, Dimitris, Ridgway, Rachel A., Nixon, Colin, McKay, Colin J., Carter, Ross, Brunton, Valerie G., Frame, Margaret C., Ashworth, Alan, Oien, Karin A., Evans, T.R. Jeffry, Sansom, Owen J.
Publikováno v:
In Gastroenterology August 2010 139(2):586-597
Autor:
Morton, Jennifer P., Karim, Saadia A., Graham, Kathryn, Timpson, Paul, Jamieson, Nigel, Athineos, Dimitris, Doyle, Brendan, McKay, Colin, Heung, Man–Yeung, Oien, Karin A., Frame, Margaret C., Evans, T.R. Jeffry, Sansom, Owen J., Brunton, Valerie G.
Publikováno v:
In Gastroenterology 2010 139(1):292-303
Autor:
Carvajal, Richard D., Piperno-Neumann, Sophie, Kapiteijn, Ellen, Chapman, Paul B., Frank, Stephen, Joshua, Anthony M., Pitulats, Josep M., Wolter, Pascal, Cocquyt, Veronique, Chmielowski, Bartosz, Evans, T.R. Jeffry, Gastaud, Lauris, Linette, Gerald, Berking, Carola, Schatchter, Jacob, Rodrigues, Manuel J., Shoushtari, Alexander N., Clemett, Delyth, Ghiorghiu, Dana, Mariani, Gabriella, Spratt, Shirley, Lovick, Susan, Barker, Peter, Kilgour, Elaine, Lai, Zhongwu, Schwartz, Gary K., Nathan, Paul
Purpose: \ud Uveal melanoma is the most common primary intraocular malignancy in adults with no effective\ud systemic treatment option in the metastatic setting. Selumetinib (AZD6244, ARRY-142886) is an\ud oral, potent, and selective MEK1/2 inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d83b1787df901a62728967f5edab3084
https://eprints.gla.ac.uk/156764/7/156764.pdf
https://eprints.gla.ac.uk/156764/7/156764.pdf
Immune checkpoint inhibitors (ICIs) targeting Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) or Programmed cell Death protein 1 (PD-1) receptors have demonstrated remarkable efficacy in subsets of patients with malignant disease. This emerging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::bdba9a60edd5143939f719c8d9d4232a
https://eprints.gla.ac.uk/151931/7/151931.pdf
https://eprints.gla.ac.uk/151931/7/151931.pdf
Autor:
Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J., James, Martin W., Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D., Wall, Lucy, Watkinson, Anthony, Hacking, Nigel, Evans, T.R. Jeffry, Collins, Peter, Hubner, Richard A., Cunningham, David, Primrose, John Neil, Johnson, Philip J., Palmer, Daniel H.
Background: \ud \ud Transarterial chemoembolisation (TACE) is the standard of care for patients with intermediate stage hepatocellular carcinoma, while the multikinase inhibitor sorafenib improves survival in patients with advanced disease. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1bf177ccb4e40a558c7a9ff1637fd004
https://eprints.gla.ac.uk/142963/1/142963.pdf
https://eprints.gla.ac.uk/142963/1/142963.pdf
Autor:
Propper, David, Jones, Keith, Anthoney, D. Alan, Mansoor, Wasat, Ford, Daniel, Eatock, Martin, Agarwal, Roshan, Inatani, Michiyasu, Saito, Masaichi, Evans, T.R. Jeffry
Background:\ud TP300, a recently developed synthetic camptothecin analogue, is a highly selective topoisomerase I inhibitor. A phase I study showed good safety and tolerability. As camptothecins have proven active in oesophago-gastric adenocarcinomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::760c1bfad6962912522c690fcd9189f0
https://eprints.gla.ac.uk/129425/1/129425.pdf
https://eprints.gla.ac.uk/129425/1/129425.pdf